Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Rosuvastatin on HDL Function in Type 2 Diabetes
NCT02185963Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rosuvastatin in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Functional High Density Lipoprotein Cholesterol at 12 weeks. Started Oct 2014; status: completed.
02
Drugs
rosuvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02185963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185963.